| Title | Author(s) | Year | View Count |  | Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes | Tam, XHL; Shiu, SWM; Leng, L; Bucala, R; Betteridge, DJ; Tan, KCB | 2011 | 99 |
 | Glycoxidized LDL increases lectin-like oxidized low density lipoprotein receptor-1 in diabetes mellitus | Shiu, SWM; Tan, KCB; Wong, Y; Leng, L; Bucala, R | 2009 | 529 |
 | Essential role for macrophage migration inhibitory factor in gastritis induced by helicobacter Pylori | Wong, BLW; Zhu, SL; Huang, XR; Juan, M; Xia, HHX; Bucala, R; Wong, BCY; Lan, HY | 2009 | 164 |
 | Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus | Tan, KCB; Shiu, SWM; Wong, Y; Leng, L; Bucala, R | 2008 | 356 |
 | Glyoxidized low-density lipoprotein upregulates soluble lectin-like oxidized ldl receptor-1 in human aortic endothelial cells. | Shiu, WMS; Wong, Y; Bucala, R; Tan, KCB | 2008 | 120 |
 | Increased serum soluble lectin-like oxidized LDL receptor-1 level in type 2 diabetes is associated with circulating advanced glycation end products | Tan, KCB; Shiu, WMS; Wong, Y; Tam, S; Bucala, R | 2007 | 103 |
 | Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes. | Tan, KC; Shiu, SW; Chow, WS; Leng, L; Bucala, R; Betteridge, DJ | 2006 | 290 |
 | Advanced glycation end products are increased in non-diabetic patients with obstructive sleep apnea but to a lesser degree than type 2 diabetic patients | Chow, WS; Tan, KCB; Lam, JCM; Lam, B; Bucala, R; Betteridge, DJ; Ip, MSM | 2006 | 77 |
 | Serum level of soluble receptor for advanced glcyation end products is associated with circulating advanced glycation end products in type 2 diabetes | Tan, KCB; Chow, WS; Shiu, SWM; Bucala, R; Betteridge, DJ | 2006 | 105 |
 | Increased serum level of soluble receptor for advanced glycation end products in type 2 diabetic patients with nephropathy | Tan, KCB; Chow, WS; Shiu, SWM; Bucala, R; Betteridge, DJ | 2006 | 72 |
 | Arterial stiffness and advanced glycation end products in type 2 diabetes mellitus | Tan, KCB; Shiu, SWM; Chow, WS; Wong, Y; Bucala, R; Betteridge, DJ | 2006 | 133 |
 | Advanced glycation endproducts in nondiabetic patients with obstructive sleep apnea | Tan, KCB; Chow, WSC; Lam, JCM; Lam, B; Bucala, R; Betteridge, J; Ip, MSM | 2006 | 56 |
 | Advanced glycation end products are increased in non-diabetic patients with obstructive sleep apnea but to a lesser degree than type 2 diabetic patients | Tan, KCB; Chow, WS; Lam, JCM; Lam, B; Bucala, R; Betteridge, DJ; Ip, MSM | 2005 | 69 |
 | Association between advanced glycation end products and serum cholesterol efflux capacity in type 2 diabetes mellitus | Zhou, H; Tan, KCB; Chow, WS; Bucala, R; Betteridge, DJ | 2005 | 76 |
 | Association between Acute-Phase Reactants and Advanced Glycation End Products in Type 2 Diabetes | Tan, KCB; Chow, WS; Tam, S; Bucala, R; Betteridge, J | 2004 | 42 |
 | Association between acute phase reactants and advanced glycation end products in type 2 diabetes mellitus | Tan, KCB; Chow, WS; Tam, SCF; Bucala, R; Betteridge, DJ | 2004 | 98 |
 | Role for macrophage migration inhibitory factor in acute respiratory distress syndrome | Lai, KN; Leung, JCK; Metz, CN; Lai, FM; Bucala, R; Lan, HY | 2003 | 114 |
 | Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients | Lo, JWS; Leung, AYH; Huang, XR; Lie, AKW; Metz, C; Bucala, R; Liang, R; Lan, HY | 2002 | 159 |
 | Endothelial dysfunction and advanced glycation end products in type 2 diabetes mellitus | Tan, KCB; Chow, WS; Ai, VHG; Metz, C; Bucala, R; Lam, KSL | 2002 | 60 |
 | Advanced glycation end products and endothelial dysfunction in type 2 diabetes | Tan, KCB; Chow, WS; Ai, VHG; Metz, C; Bucala, R; Lam, KSL | 2002 | 49 |
|